Ovarian Cancer, news on ovarian caner, early detection of ovarian cancer and treatment, symptoms and signs of ovarian cancer, clinical trials and ovarian cancer information.

 
 

International Efforts Join to Increase Understanding and Treatment of Ovarian Cancer


While ovarian cancer accounts for only 6% percent of all cancers among women, its mortality rate is very high, ranking it the fourth highest cancer killer of women.

Ovarian Cancer and Abdominal Chemo


NCI issues clinical announcement for preferred method of treatment of ovarian cancer.

Abdominal Chemo Boosts Survival In Ovarian Cancer Patients


Study led by Johns Hopkins Kimmel Cancer Center suggests new treatment standard for advanced ovarian cancer.

Aggressive Surgery Best Option for Advanced-Stage Ovarian Cancer Patients


Surgery to remove as much tumor as possible at the initial operation is the best option for most patients with ovarian cancer.

Ovarian Cancer: Know the Early Symptoms


The symptoms of ovarian cancer tend to mimic those of other conditions, including digestive and urinary disorders.

Women Undergoing Hysterectomy Before Age 65 Derive Survival Benefit From Ovarian Conservation


Ovarian conservation at the time of hysterectomy (in women who are not at increased risk for ovarian cancer) may lead to longer survival.

Hormone Replacement Therapy Does Not Increase Risk for Ovarian Cancer in Women with BRCAmutations


Due to considerable risk of ovarian cancer and its high lethality, women would be best advised to undergo prophylactic salpinoophorectomy, which essentially eliminates the risk of ovarian cancer.

Ovarian Cancer: Living Longer


Women with ovarian cancer are more likely in 2006 to receive a treatment that will significantly extend their lives.

Announcement for Preferred Method of Treatment for Advanced Ovarian Cancer


New method extends overall survival for women with advanced ovarian cancer by about a year.

Drinking Tea Associated with Lower Risk of Ovarian Cancer


Women who drank at least two cups of tea a day had a lower risk of ovarian cancer than those who did not drink tea.

Molecular Differences Between Low-Grade and High-Grade Ovarian Cancers


Patients with serous low grade or high grade ovarian cancer currently receive the same treatment, which is surgery followed by chemotherapy.

Ovarian Cancer Screening Using Ultrasound and CA125 Finds both Early and Late Stage Cancers


These findings on ovarian cancer are based on an analysis of the trial participants' initial screening tests.

Subtle Signs of Ovarian Cancer Can Combine To Become Serious Symptoms


Symptoms of ovarian cancer are subtle and sometimes are not recognized until it is too late for effective treatment.

Ovarian Cancer Often Announces Its Presence Through Symptoms


More than a third of women with ovarian cancer report symptoms of the disease at least four months before diagnosis.

Early Clinical Signs of Ovarian Cancer


Many women diagnosed with ovarian cancer actually complained of symptoms of the disease at least four months before they were diagnosed.

Study Suggests Protein May Be Early Warning for Ovarian Cancer


Penn State researchers have found a sign that could lead to earlier detection and treatment of ovarian cancer.

Social Support Linked To Prognostic Marker for Ovarian Cancer


Psychosocial factors may indeed be important clinically in the course of ovarian cancer.

Ovarian Cancer Still a Silent Killer


Education about ovarian cancer is essential, as almost 70 percent of women with the common epithelial ovarian cancer are not diagnosed until the disease is advanced in stage.

Home Cancer Treatment Ovarian Cancer Symptoms and Treatment

2 page(s) << < 1 2 >>

This category only

BSI-201 Demonstrates Significant Tumor Growth Inhibition In Ovarian Cancer Studies
BiPar Sciences announced positive preclinical data demonstrating the activity of its lead poly ADP-ribose polymerase (PARP) inhibitor, BSI-201, in ovarian cancer models.
Diagnostic Tests Identify Ovarian Cancer Progression, Apoptosis
The FAS-detect IHC test was used in evaluating 321 samples of serous ovarian cancer.
BioNumerik Commences Ovarian Cancer Trial On Karenitecin
BioNumerik Pharmaceuticals initiates global Phase III clinical trial of BioNumerik's anticancer drug candidate known as Karenitecin in advanced ovarian cancer patients.
Northwest Biotherapeutics Conducts Ovarian Cancer Clinical Trial
Northwest Biotherapeuticsannounced that a Phase I/II clinical trial in at least 30 patients, using DCVax-L for recurrent ovarian cancer, has begun
Link Between Cell Survival Proteins, Ovarian Cancer Aggressiveness
Scientific team has found that the elevated levels of certain proteins typically associated with keeping cancer cells alive may actually correspond with improved patient survival in ovarian cancer.
Eating Flavonoid-Rich Diet Helps Women Decrease Risk Of Ovarian Cancer
Frequent consumption of foods containing the flavonoid kaempferol, including non-herbal tea and broccoli, was associated with a reduced risk of ovarian cancer.


 
Privacy Policy | Disclaimer | About Us | Editorial Review Process | Advertise | Contact | Health News
© Copyright 2004-2008 eMaxHealth.com. All Rights Reserved. Hareyan Publishing LLC does not provide medical advice.